1 / 22

Inflammatory bowel disease

Inflammatory bowel disease. By: Elias S. Maruf A. IBD. Idiopathic and chronic intestinal inflammation. Two major types: Crohn’s disease(CD) Ulcerative colitis(UC) CD 1 st seen by the German surgeon Wilhelm Fabry in 1623

zeheb
Download Presentation

Inflammatory bowel disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Inflammatory bowel disease By: Elias S. Maruf A.

  2. IBD • Idiopathic and chronic intestinal inflammation. • Two major types: Crohn’s disease(CD) Ulcerative colitis(UC) • CD • 1st seen by the German surgeon Wilhelm Fabry in 1623 • Later described and named after US physician Burril B. Crohn • UC • 1st described by the British physician Sir Samuel Wilks in 1958

  3. Epidemiology – CD, UC • Highest incidence ratesNorth America, Northern Europe, UK • Low incidence Areas Southern Europe, Asia, Most Developing countries • Age of onset: Two peaks  15-30yrs, 60-80y. • Sex: M:F UC  1:1 CD  1.1-1.8:1 • Race: CD (N.America) per 100,000 P. • Whites > African A. > Asian A. > Hispanic A. 43.6 29.8 5.9 4.1 • Both more prevalent in Jewish people than any other ethnic group

  4. GeneticsFamilial aggregation of IBD 1st reported in 1930+ve Family Hx – the largest independent risk FactorPrevalence in 1st degree Relatives • Concordance b/n P’t and 1st degree relative • Disease type  75-80% • Disease pattern  64% • Extraintestinal manifestation  70%

  5. Genetics Cont… • Twin study • Pooled systematic concordance analysis Monozygotic twins: CD – 37%, UC – 10% Dizygotic twins: CD – 7% , UC – 3% • MT > DT, CD > UC • IBD - Polygenic disease • So far – 12 chromosomes identified 16,12,6,14,5,19,1,7,3 (IBD 1-9) • Some specific gene loci – mapped • Ch.16 – NOD2(card15) associated with CD • Ch. 5 – OCTN1,OCTN2 • Ch. 6 – encodes for MHC mutations in HLA Alleles: HLA DRB*0103 / B27 / B35 / B44 • Mutation in IL23R gene – protective against CD

  6. Environmental & other factors • Life style • Urban > Rural • Poor socioeconomic status - Risk • Excessive sanitation - Risk • Smoking :Aggravate the course of CD Risk of UC • Psychological stress Adverse life events/day to day stress activity of IBD (worsening, Relapse) • Infectios agents Normal flora ?M.paratuberculosis, Paramyxovirus, Helicobactor H.?others – Salmonella,Shigella, Campylobactor • Drugs: OCP – weak association with CD NSAID • Breast feeding – protective against IBD • Appendectomy : ?protective for UC, ?complications of CD

  7. Immunopathology • GI mucosal surface • A physical interface of immune system with outside world : rich in lymphoid tissue • Bombarded with high Ag load • Harbors >500 sp. of micro flora • Normal state - Immune tolerance • Non-Responsiveness (inhibited immune function) • Mechanism- not clearly understood • Dysregulated immune function - IBD

  8. Healthy Gut • A complex network ofLymphoid, non-Lymphoid cells, Humoral factors • Balanced differentiation of T-helper cellsEffecter c.(Th1,Th2,Th17) Regulatory c. (Tr, Th3) • Tightly regulated cytokine network • Tightly regulated immunity

  9. IBD – Dysregulated immune response • Leaky barrier – luminal Ag gain access • Commensals recognized as pathogens • Expression of differentprofile & pattern of receptors • Imbalanced T-helper cell differentiationeffector cellsCD: Th0Th1 (INF∂,IL12)UC: Th0Th2 (IL5) • NK cells • Cyclic activation of macrophages • Continious inappropriate inflammatory response

  10. Ulcerative Colitis • A mucosal disease (non-transmural) • Relapsing • Involve rectum and colon • 40-45% - rectum & recto sigmoid • 30-40% - extend beyond sigmoid • 20% - total colitis • 10-20% - backwash ileitis • continuous spread • Mild inflammation – Erythema with fine granular surface • More sever disease – ulceration with hemmge and edema • Long standing disease – inflammatory polyps • Major histologic feature • Distorted crypt architecture • Cyptitis, crypt abscess

  11. UC cont… • Typical presentation • Diarrhea,tenesmus,passage of pus,mucuscrampy abdominal pain • Site specific presentation • Distal disease (proctitis): Passage of fresh blood, constipation Abdominal pain – Rare • Proximal disease (colon) gross bloody diarrhea, abd. Pain nausea, vomiting, W’t loss • Imading studies • Plain abd. Film: colon thickning, dilatation • Barium: thickned mucosa with superficial ulcer Deep ulcer – “collar button” loss of haustration • CT – mild mural thickning (<1.5cm) with inhomogenous wall density

  12. UC cont….. • Natural course • 50% of the P’ts – clinical remission at any given time • 90% - intermittent course • Complications • Massive hemorrhage (1%) • Toxic megacolon (5%) • Perforation • ?Rarely – colonic obstruction • Long term - malignancy

  13. Croh’ns disease • Transmural, Relapsing • Affect any part of GI – from mouth to anus • Location: Terminal ileum – 47% colon – 28%, ileocolon – 21% upper GI – 3% • Rectum- spared • Segmental involvement with skip areas • Disease behaviour • Non-stricturing/non-penetrating – 70% • Stricturing – 17%, Penetrating – 13% • Mild disease: aphtous ulcerations • More active disease: “cobble stone” appearance May involve liver & pancreas • Major histologic finding: noncaseating Granulomas

  14. CD cont…… • Clinical presentation – depends on the site • Ileocolitis : common site - terminal ileumRLQ pain, diarrhea, palpable mass low grade fever, w’t loss edema / bowel wall thickening fibrosis narrowing of the lumen ( radiographic “string” sign) • Jejunoileitis : loss of digestive/absorptive surface Malabsorption, steatorrhea • Colitis: Bloody diarrhea, abd cramp, tenesmus Massive bleeding (1-2%) • Perianal disease (1/3 of p’ts) : incontinence, anal stricture, anorectal fistula, abscess • Gastro duodenal: Nausea, vomiting, epigastric pain

  15. CD cont…. • Natural course • 67-73% - chronic intermittent course • 10-13% - remain in remission for several yrs • After 20 yrs – most require surgery • Complication • Strictures - Bowel obstruction (40% of cases) • Fistula, Abscess • Malabsorbtion syndrome • rarely – massive hemmorhage

  16. UC CD

  17. UC CD

  18. UC CD

  19. Extra intestinal manifestations • In 25% of IBD cases • Usually seen with colonic involvement • Involve any organ system • Skin, joints, eyes,biliary tract commonlyaffected • Mainly immune mediated • Most respond to Rx ofthe underlying disease

  20. The common ones • Skin: Erythema nodosum, Pyoderma gangrenosum • Joints : Peripheral arthritis, Ankylosing spondylitis Sacroliitis • Ocular : conjunctivitis, anterior uveitis / iritis, episcleritis • Hepatobiliary : Hepatic steatosis, Cholelithiasis P. sclerosing cholangitis • Urologic : Nephrolithiasis, ureteral obstruction, Fistulas

  21. THANK YOU

More Related